SCHEMBL18335062

SCHEMBL18335062

CC(C)(C)OC(=O)NCCc1ncc(C#CC2CC2)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGLN1 Q9GZT9 1/20 0.41
▸ STK17B O94768 1/20 0.41
▸ STK17A Q9UEE5 1/20 0.41
▸ HPGD P15428 3/20 0.38
▸ HTT P42858 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18335135 0.83 EGLN1 (0.40) EGLN1
SCHEMBL18335102 0.82 EGLN1 (0.41) EGLN1STK17BSTK17ACHRNB2CHRNA2
SCHEMBL18335152 0.80 EGLN1 (0.39) EGLN1STK17BSTK17ACHRNB2CHRNA2
SCHEMBL18335078 0.80 EGLN1 (0.39) EGLN1STK17BSTK17AGAACHRNB2
SCHEMBL18335095 0.80 EGLN1 (0.39) EGLN1STK17BSTK17ACHRNB2CHRNA2
SCHEMBL18335116 0.79 EGLN1 (0.39) EGLN1STK17BSTK17ACHRNB2CHRNA2
SCHEMBL2129621 0.79 ALDH1A1 (0.49) STK17BSTK17AHPGDHTTALDH1A1
SCHEMBL18335084 0.78 EGLN1 (0.38) EGLN1STK17BSTK17ACHRNB2CHRNA2
SCHEMBL16552184 0.77 STK17B (0.47) STK17BSTK17AHPGDHTTALDH1A1
SCHEMBL18335169 0.77 EGLN1 (0.40) EGLN1MEN1KMT2ACHRNB2CHRNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10029986-B2 Alkynyl pyridine-substituted amide compound and pesticide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-07-24 — — US disclosed
US-20170008847-A1 ALKYNYL PYRIDINE-SUBSTITUTED AMIDE COMPOUND AND PESTICIDE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-01-12 — — US disclosed
EP-3109234-A1 ALKYNYLPYRIDINE-SUBSTITUTED AMIDE COMPOUND AND NOXIOUS ORGANISM CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2016-12-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10029986-B2 Alkynyl pyridine-substituted amide compound and pesticide CHRM1, CHRM2, CHRM3 EGLN1 1022/4885STK17B 2938/4885STK17A 2474/4885
US-20170008847-A1 ALKYNYL PYRIDINE-SUBSTITUTED AMIDE COMPOUND AND PESTICIDE CHRM1, CHRM2, CHRM3 EGLN1 1022/4885STK17B 2938/4885STK17A 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback